| Dr Michael Lofgren, MD | |
|
895 City Center Blvd Ste 300, Newport News, VA 23606-3080 | |
| (757) 873-3500 | |
| (757) 591-5240 |
| Full Name | Dr Michael Lofgren |
|---|---|
| Gender | Male |
| Speciality | Plastic And Reconstructive Surgery |
| Experience | 21 Years |
| Location | 895 City Center Blvd Ste 300, Newport News, Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104099241 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208200000X | Plastic Surgery | 0101244519 (Virginia) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Plastic Surgery Center Of Hampton Roads Pc | 4587751227 | 4 |
News Archive
Cancer Research UK funded scientists have conducted the first whole-genome scan of the brain tumour meningioma and revealed a genetic region that increases the risk of developing the disease, according to research published in Nature Genetics today.
Experts in Sweden are warning that the new U.S. recommendations for lowering cholesterol levels would increase the risk of harmful side effects with no overall reduction in deaths.
Positive activity interventions (PAIs) offer a safe, low-cost, and self-administered approach to managing depression and may offer hope to individuals with depressive disorders who do not respond or have access to adequate medical therapy, according to a comprehensive review article in The Journal of Alternative and Complementary Medicine, a peer-reviewed journal published by Mary Ann Liebert, Inc.
Albumedix Ltd. (‘Albumedix'), an enabler of advanced therapies and the world leader in recombinant human albumin (rAlb), announced today that they have entered into a collaboration agreement with Cell and Gene Therapy Catapult (CGT Catapult) to investigate the use of Albumedix´ proprietary albumin-based solutions for advanced therapy applications, including viral vectors manufacturing.
Researchers from Boston University School of Medicine (BUSM) have discovered a new gene therapy that may prevent the progression of emphysema. The study, which appears on-line in the Journal of Clinical Investigation, describes a method to express therapeutic genes in lung tissue for a lifetime after only a single treatment.
› Verified 6 days ago
| Entity Name | Plastic Surgery Center Of Hampton Roads Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639258478 PECOS PAC ID: 4587751227 Enrollment ID: O20071029000187 |
News Archive
Cancer Research UK funded scientists have conducted the first whole-genome scan of the brain tumour meningioma and revealed a genetic region that increases the risk of developing the disease, according to research published in Nature Genetics today.
Experts in Sweden are warning that the new U.S. recommendations for lowering cholesterol levels would increase the risk of harmful side effects with no overall reduction in deaths.
Positive activity interventions (PAIs) offer a safe, low-cost, and self-administered approach to managing depression and may offer hope to individuals with depressive disorders who do not respond or have access to adequate medical therapy, according to a comprehensive review article in The Journal of Alternative and Complementary Medicine, a peer-reviewed journal published by Mary Ann Liebert, Inc.
Albumedix Ltd. (‘Albumedix'), an enabler of advanced therapies and the world leader in recombinant human albumin (rAlb), announced today that they have entered into a collaboration agreement with Cell and Gene Therapy Catapult (CGT Catapult) to investigate the use of Albumedix´ proprietary albumin-based solutions for advanced therapy applications, including viral vectors manufacturing.
Researchers from Boston University School of Medicine (BUSM) have discovered a new gene therapy that may prevent the progression of emphysema. The study, which appears on-line in the Journal of Clinical Investigation, describes a method to express therapeutic genes in lung tissue for a lifetime after only a single treatment.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michael Lofgren, MD 895 City Center Blvd Ste 300, Newport News, VA 23606-3080 Ph: (757) 873-3500 | Dr Michael Lofgren, MD 895 City Center Blvd Ste 300, Newport News, VA 23606-3080 Ph: (757) 873-3500 |
News Archive
Cancer Research UK funded scientists have conducted the first whole-genome scan of the brain tumour meningioma and revealed a genetic region that increases the risk of developing the disease, according to research published in Nature Genetics today.
Experts in Sweden are warning that the new U.S. recommendations for lowering cholesterol levels would increase the risk of harmful side effects with no overall reduction in deaths.
Positive activity interventions (PAIs) offer a safe, low-cost, and self-administered approach to managing depression and may offer hope to individuals with depressive disorders who do not respond or have access to adequate medical therapy, according to a comprehensive review article in The Journal of Alternative and Complementary Medicine, a peer-reviewed journal published by Mary Ann Liebert, Inc.
Albumedix Ltd. (‘Albumedix'), an enabler of advanced therapies and the world leader in recombinant human albumin (rAlb), announced today that they have entered into a collaboration agreement with Cell and Gene Therapy Catapult (CGT Catapult) to investigate the use of Albumedix´ proprietary albumin-based solutions for advanced therapy applications, including viral vectors manufacturing.
Researchers from Boston University School of Medicine (BUSM) have discovered a new gene therapy that may prevent the progression of emphysema. The study, which appears on-line in the Journal of Clinical Investigation, describes a method to express therapeutic genes in lung tissue for a lifetime after only a single treatment.
› Verified 6 days ago
Thomas Randall Blanchard, MD Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 895 City Center Blvd, Suite #300, Newport News, VA 23606 Phone: 757-873-3500 Fax: 757-591-5240 | |
Patricia Katherine Gomuwka, MD Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 12695 Mcmanus Blvd, Bldg 7 Suite A, Newport News, VA 23602 Phone: 757-872-8597 Fax: 757-872-0650 | |
Alexander Mcarthur Iii, M.D. Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 895 City Center Blvd, Suite 300, Newport News, VA 23606 Phone: 757-873-3500 Fax: 757-591-5240 | |
Dr. Michael Cohen, MD Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 895 City Center Blvd, Newport News, VA 23606 Phone: 757-873-3500 Fax: 757-814-2161 | |
Peter J Vonu, M.D. Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 895 City Center Blvd, Suite #300, Newport News, VA 23606 Phone: 757-873-3500 Fax: 757-591-5240 | |
Dr. Glenn Harvey Shepard, M.D. Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 36 Barclay Rd, Newport News, VA 23606 Phone: 757-930-3526 Fax: 757-930-0118 |